Built to deliver ROI for less cost, Mailchimp now combines unified data with powerful automation across email and messaging Product innovations available in 185 countries and territories across North ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

New York, NY – First Due, the leading provider of end-to-end software for Fire and EMS agencies, announced the release of Advanced Data Insights, a major expansion of its data and analytics solution.

Over 350,000 members have joined the waitlist since May, underscoring the excitement for one product that can pair blood biomarkers with 24/7 wearable data Since previewing the feature in May, more ...

LOGAN, Utah--(BUSINESS WIRE)--Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View™ Imager Plus, a next-generation imaging device designed to ...

WHOOP, the human performance company, today announced a partnership with Unilabs, a leading international provider of medical ...

Oldham provided Q3 guidance: "we're forecasting our third quarter revenue to be approximately $440 million, plus or minus $20 million. We expect gross margins in the third quarter to improve to around ...

Comparative restricted mean survival time (RMST) analysis of survival in advanced hepatocellular carcinoma (aHCC) from pivotal phase III trials: IMbrave-150, ORIENT-32, CARES-310, HIMALAYA, and CM-9DW ...

Comparable efficacy and safety of taletrectinib for advanced ROS1+ non–small cell lung cancer across pivotal studies and between races and world regions.